Check out this scientific paper.
Not sure if it’s the same 3e10 patry’s is Using, but it does seem to be quite similar in name and mechanism of action.
http://mct.aacrjournals.org/content/molcanther/early/2012/10/01/1535-7163.MCT-12-0476-T.full.pdf
These scientists also made quite a bold statement about the significance of this type drug in cancer therapy in their abstract,
“The use of cell-penetrating bispecific antibodies in targeted molecular therapy will significantly broaden the spectrum of accessible intracellular targets and may have a profound impact in cancer therapy. Mol Cancer Ther; 11(10); 1– 5. !2012 AACR.“
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.731M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 92467639 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 55715191 | 24 |
View Market Depth
| Last trade - 16.21pm 16/07/2025 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable